Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 11, 2024 | Veradermics | $75.0M Series B | Amanda Birdsey-Benson | Vlad Coric, Connecticut Innovations, J.W. Childs Associates, Patrick Enright, Osage University Partners, Surveyor Capital |
| Oct 30, 2024 | Leal Therapeutics | $45.0M Other Equity | Thomas Cahill | Alexandria Venture Investments, John Gustofson, Euclidean Capital, OrbiMed |
| Mar 1, 2023 | Switch Therapeutics | $52.0M Series A | Insight Partners, Alicia Iruzun Lafitte | Alta Partners, Astellas Venture Management, Longwood Fund, Bold Capital Partners, Digitalis Ventures, Dolby Family Ventures, Eli Lilly and Company, Freeflow Ventures, Ono Venture Investment, Upfront Ventures |